An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Conclude your understanding of lymphoma with an in-depth look at its signs and symptoms, from common indicators to subtle clues.

Speaker : Dr Suvir Singh

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

Join Prof. Solange Peters as she explores post-progression strategies after first-line third-generation ALK inhibitors in NSCLC.

Speakers : Prof. Solange Peters

Oropharyngeal Cancer in Relation to HPV Status

Learn about the occurrence of oropharyngeal cancer in HPV negative patients through different case presentations.

Speakers : Dr. Ashish M Kaushal

Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma

Dr. Rohit R Pai compares Nimotuzumab plus chemoradiotherapy vs. placebo plus chemoradiotherapy in locally advanced nasopharyngeal carcinoma (LA-NPC).

Speakers : Dr. Rohit R Pai - Speaker

Role of Nimotuzumab in Management of Nasopharyngeal Cancer

Explore the role of Nimotuzumab in Nasopharyngeal Cancer management with Dr. Abhishek Raj, focusing on targeted therapy and improved patient outcomes.

Speakers : Dr. Abhishek Raj

Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World

Explore the benefits of CDK4/6 inhibitors in HR+/HER2- advanced breast cancer with Dr. Shailesh Bondarde.

Speakers : Dr Shailesh Bondarde

Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients

Discover how CDK4/6 inhibitors extend progression-free survival (PFS) and overall survival (OS) in HR+/HER2- metastatic breast cancer (mBC) patients.

Speakers : Dr Parveen Jain

First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials

Explore expert insights on first-line maintenance therapy for metastatic urothelial carcinoma in this panel discussion featuring Dr. Tushar Patil, Dr. Varun Nagori, and Dr. Amol Dongre.

Speakers : Dr Tushar Patil ,Dr Varun Nagori ,Dr Amol Dongre

CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World

Explore how CDK4/6 inhibitors improve overall survival in HR+/HER2- advanced breast cancer patients with Dr. Anju Malhotra.

Speakers : Dr. Anju Malhotra

Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion

Explore advanced urothelial carcinoma treatment strategies with Dr. Nagender Sharma. Discover immunotherapy, targeted therapies, and personalized approaches in this expert-led oncology discussion.

Speakers : Dr Nagendra Sharma

From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD

xplore MRD-guided therapies in adult R/R B-ALL, with insights on CAR-T, blinatumomab, and personalized strategies for achieving long-term remission.

Speakers : Dr Nitin Gupta ,Dr Isha Kaul ,Dr Riyaz Ahmed


Recommended News For You

Muscle Strength, Fitness Linked to Lower Mortality Risk in Patients With Cancer

According to JAMA, statin use may increase cancer-related survival in breast cancer patients.

Immunotherapy-TACE Regimen Boosts PFS in Unresectable Liver Cancer

Males with early-onset colorectal cancer are at risk, according to a study.

Trump Issues Gag Order for CDC, FDA; Stalled Hearing for RFK Jr.; Sex After Cancer

Alcohol Causes Cancer. We Should Be Drinking Less.

Getting ahead of head and neck cancer

Recommended Articles For You

Practical Concepts in Hematology and Patient Outcomes 

Innovative Bioengineering Approaches for Erectile Function Recovery After Radical Prostatectomy 

Clinical Pharmacology of Iron Homeostasis Regulatory Therapeutics 

Does Lactate Signal Anemia? Exploring the Complexities of Hyperlactatemia and Red Blood Cell Health 
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study opens up possibility of bespoke prostate cancer treatment

2.

Why Encouragement May Not Improve Motivation in Depression

3.

Study Finds Actionable Mutations in Brain Mets of Breast Cancer Patients

4.

A person's susceptibility to papillary thyroid cancer may be determined by variations in telomere lengthening genes.

5.

Pirtobrutinib May Be Beneficial in Follicular Lymphoma with Severe Pretreatment.

1.

Prevention Through Survivorship-Focused Strategies for Preserving Functional Independence After Cancer

2.

Patient Management for Bone Marrow Functional Recovery Pathways

3.

Uncovering the Causes of Thrombocytosis: A Journey to Improved Health

4.

Targeted Approaches to Breast Cancer Liver Metastases: Surgery, Ablation, and Survival Insights

5.

Hematopoietic Immune Microenvironment Plasticity: Mechanisms, Clinical Implications, and Emerging Therapeutics

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

2.

Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.

3.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV

4.

Early Cancer Detection Saves Lives

5.

How Platelet Disorders Can Affect the Body

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot